Investing Profile

Carole Nuechterlein

VC
Head, Roche Venture Fund at F.Hoffmann-La Roche
Photo of Carole Nuechterlein, F.Hoffmann-La Roche

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Michigan Network
133 CONNECTIONS
cb
11
CompanyStageDateRound SizeTotal Raised
Splice Bio
Series BJun 2025$140M
$190M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Beat Steffen (Novartis Venture Fund)
Enthera
Series AJan 2021$8M
$8M
Arch Oncology
Series AAug 2016$86M
$86M
Co-investors: Jill carroll (SR One)
Second Genome
Series BApr 2016$51M
$58M
Co-investors: Jill carroll (SR One), Mike Carusi (Lightstone Ventures), Jason Lettmann (Morgenthaler Ventures)
AveXis
Series DSep 2015$65M
Series CJan 2015$10M
$75M
Lysosomal Therapeutics
Series AFeb 2015$20M
SeedMay 2014$5M
$25M
Co-investors: Bruce Booth (Atlas Venture)
Alios BioPharma
Series BApr 2014$41M
Series AJun 2009$24M
Series AFeb 2009$8M
$73M
Co-investors: Jens Eckstein (Apollo Health Ventures)
Head, Roche Venture Fund F.Hoffmann-La Roche2001 - Present
General Counsel SangStat1998 - 2001
University of Michigan JD